Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

 

Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient
J

Updates on MCL: Ibrutinib + Ven, Len + Rituximab, 1L Sequential Immunochemotherapy, LOXO-305, Lisocabtagene Maraleucel

By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING James Gerson
By Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient FEATURING James Gerson
0 views
July 15, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
New Therapies and Current Patient Management of Lymphomas
16:47
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Overview of New Therapies and Current Management of CLL, SLL & R…

Feat. J. Gerson
08:09
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Updates on MCL: Ibrutinib + Ven, Len + Rituximab, 1L Sequential Immu…

Feat. J. Gerson
07:39
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn 2021 Updates on PTCL: Does the Addition of Romidepsin to CHOP …

Feat. J. Svoboda
07:09
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

Older Adults With cHL: Considering Brentuximab Vedotin Mono & Co…

Feat. J. Svoboda
10:50
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

ASH Updates on R/R cHL: How to Consider Pembro-GVH? What Is the Role…

Feat. J. Svoboda
17:46
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn Expert Discussion on Lymphoma: Efficacy of Acalabrutinib for S…

Feat. S. Schuster, J. Gerson, J. Svoboda, E. Chong, S. Nasta, D. Beach, G. Hanna
10:41
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

ASH Updates on Large Cell & Aggressive Lymphomas: Antibody Lonca…

Feat. S. Nasta
09:00
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

ASH Updates on Lymphomas: 1L (Axi-Cel) in High-Risk DLBCL, Safety, D…

Feat. S. Nasta
09:41
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn ASH Highlights on PI3Ki & BTKi for R/R MZL: How Effective …

Feat. E. Chong
10:32
Penn Medicine's 2021 Updates in Care of the Hematologic Malignancies Patient

UPenn ASH Highlights on CAR-T & Bispecific Antibodies for iNHL: …

Feat. E. Chong